Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.003 |
mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.004 |
mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.005 |
mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.006 |
mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.091 | 0.007 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.083 | 0.007 |
mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.007 |